NSRX Overview

Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.

Wall Street analysts forecast NSRX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NSRX is19.00 USD with a low forecast of 19.00 USD and a high forecast of 19.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Nasus Pharma Ltd revenue for the last quarter amounts to NaN USD, decreased

Nasus Pharma Ltd. EPS for the last quarter amounts to USD, decreased

Nasus Pharma Ltd (NSRX) has 0 emplpoyees as of April 03 2026.

Today NSRX has the market capitalization of 27.52M USD.